diatrizoate meglumine has been researched along with thromboxane a2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kormano, M; Paajanen, H | 1 |
| Banitt, PF; Dai, HB; Nunez, BN; Piana, RN; Sellke, FW | 1 |
2 other study(ies) available for diatrizoate meglumine and thromboxane a2
| Article | Year |
|---|---|
Prostacyclin (PGI2) and thromboxane (TXA2) levels during intravenous contrast medium administration in CT.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Contrast Media; Diatrizoate; Diatrizoate Meglumine; Epoprostenol; Humans; Infusions, Parenteral; Middle Aged; Pelvis; Radioimmunoassay; Thromboxane A2; Thromboxane B2; Thromboxanes; Tomography, X-Ray Computed | 1985 |
Coronary microvascular responses after exposure to iodinated contrast media.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Bradykinin; Calcimycin; Coronary Vessels; Diatrizoate Meglumine; Endothelium, Vascular; Female; Male; Microcirculation; Muscle, Smooth, Vascular; Nitroprusside; Prostaglandin Endoperoxides, Synthetic; Serotonin; Swine; Thromboxane A2; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents | 1994 |